Global Neurovascular Interventional Devices Market Growth 2024-2030

Publication ID:

LPI08252132

Publication Date:

August 16, 2024

Pages:

109

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Neurovascular Interventional Devices market size was valued at US$ million in 2023. With growing demand in downstream market, the Neurovascular Interventional Devices is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Neurovascular Interventional Devices market. Neurovascular Interventional Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neurovascular Interventional Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neurovascular Interventional Devices market.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Neurovascular Interventional Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neurovascular Interventional Devices market. It may include historical data, market segmentation by Type (e.g., Embolization Coils, Carotid Stents), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neurovascular Interventional Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neurovascular Interventional Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neurovascular Interventional Devices industry. This include advancements in Neurovascular Interventional Devices technology, Neurovascular Interventional Devices new entrants, Neurovascular Interventional Devices new investment, and other innovations that are shaping the future of Neurovascular Interventional Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neurovascular Interventional Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Neurovascular Interventional Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neurovascular Interventional Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neurovascular Interventional Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neurovascular Interventional Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neurovascular Interventional Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neurovascular Interventional Devices market.
Market Segmentation:
Neurovascular Interventional Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Embolization Coils
Carotid Stents
Intracranial Stents
Flow Diverters
Intrasaccular Devices
Others
Segmentation by application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
W.L. Gore & Associates
Abbott Laboratories
Stryker Corporation
Medtronic PLC
Terumo Corporation
Johnson & Johnson
Penumbra, Inc.
Boston Scientific Corporation
Merit Medical Systems, Inc.
Microport Scientific Corporation
Cardinal Health
Key Questions Addressed in this Report
What is the 10-year outlook for the global Neurovascular Interventional Devices market?
What factors are driving Neurovascular Interventional Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurovascular Interventional Devices market opportunities vary by end market size?
How does Neurovascular Interventional Devices break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neurovascular Interventional Devices Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Neurovascular Interventional Devices by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Neurovascular Interventional Devices by Country/Region, 2019, 2023 & 2030
2.2 Neurovascular Interventional Devices Segment by Type
2.2.1 Embolization Coils
2.2.2 Carotid Stents
2.2.3 Intracranial Stents
2.2.4 Flow Diverters
2.2.5 Intrasaccular Devices
2.2.6 Others
2.3 Neurovascular Interventional Devices Sales by Type
2.3.1 Global Neurovascular Interventional Devices Sales Market Share by Type (2019-2024)
2.3.2 Global Neurovascular Interventional Devices Revenue and Market Share by Type (2019-2024)
2.3.3 Global Neurovascular Interventional Devices Sale Price by Type (2019-2024)
2.4 Neurovascular Interventional Devices Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.4.4 Others
2.5 Neurovascular Interventional Devices Sales by Application
2.5.1 Global Neurovascular Interventional Devices Sale Market Share by Application (2019-2024)
2.5.2 Global Neurovascular Interventional Devices Revenue and Market Share by Application (2019-2024)
2.5.3 Global Neurovascular Interventional Devices Sale Price by Application (2019-2024)
3 Global Neurovascular Interventional Devices by Company
3.1 Global Neurovascular Interventional Devices Breakdown Data by Company
3.1.1 Global Neurovascular Interventional Devices Annual Sales by Company (2019-2024)
3.1.2 Global Neurovascular Interventional Devices Sales Market Share by Company (2019-2024)
3.2 Global Neurovascular Interventional Devices Annual Revenue by Company (2019-2024)
3.2.1 Global Neurovascular Interventional Devices Revenue by Company (2019-2024)
3.2.2 Global Neurovascular Interventional Devices Revenue Market Share by Company (2019-2024)
3.3 Global Neurovascular Interventional Devices Sale Price by Company
3.4 Key Manufacturers Neurovascular Interventional Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurovascular Interventional Devices Product Location Distribution
3.4.2 Players Neurovascular Interventional Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Neurovascular Interventional Devices by Geographic Region
4.1 World Historic Neurovascular Interventional Devices Market Size by Geographic Region (2019-2024)
4.1.1 Global Neurovascular Interventional Devices Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Neurovascular Interventional Devices Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Neurovascular Interventional Devices Market Size by Country/Region (2019-2024)
4.2.1 Global Neurovascular Interventional Devices Annual Sales by Country/Region (2019-2024)
4.2.2 Global Neurovascular Interventional Devices Annual Revenue by Country/Region (2019-2024)
4.3 Americas Neurovascular Interventional Devices Sales Growth
4.4 APAC Neurovascular Interventional Devices Sales Growth
4.5 Europe Neurovascular Interventional Devices Sales Growth
4.6 Middle East & Africa Neurovascular Interventional Devices Sales Growth
5 Americas
5.1 Americas Neurovascular Interventional Devices Sales by Country
5.1.1 Americas Neurovascular Interventional Devices Sales by Country (2019-2024)
5.1.2 Americas Neurovascular Interventional Devices Revenue by Country (2019-2024)
5.2 Americas Neurovascular Interventional Devices Sales by Type
5.3 Americas Neurovascular Interventional Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurovascular Interventional Devices Sales by Region
6.1.1 APAC Neurovascular Interventional Devices Sales by Region (2019-2024)
6.1.2 APAC Neurovascular Interventional Devices Revenue by Region (2019-2024)
6.2 APAC Neurovascular Interventional Devices Sales by Type
6.3 APAC Neurovascular Interventional Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Neurovascular Interventional Devices by Country
7.1.1 Europe Neurovascular Interventional Devices Sales by Country (2019-2024)
7.1.2 Europe Neurovascular Interventional Devices Revenue by Country (2019-2024)
7.2 Europe Neurovascular Interventional Devices Sales by Type
7.3 Europe Neurovascular Interventional Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neurovascular Interventional Devices by Country
8.1.1 Middle East & Africa Neurovascular Interventional Devices Sales by Country (2019-2024)
8.1.2 Middle East & Africa Neurovascular Interventional Devices Revenue by Country (2019-2024)
8.2 Middle East & Africa Neurovascular Interventional Devices Sales by Type
8.3 Middle East & Africa Neurovascular Interventional Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurovascular Interventional Devices
10.3 Manufacturing Process Analysis of Neurovascular Interventional Devices
10.4 Industry Chain Structure of Neurovascular Interventional Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurovascular Interventional Devices Distributors
11.3 Neurovascular Interventional Devices Customer
12 World Forecast Review for Neurovascular Interventional Devices by Geographic Region
12.1 Global Neurovascular Interventional Devices Market Size Forecast by Region
12.1.1 Global Neurovascular Interventional Devices Forecast by Region (2025-2030)
12.1.2 Global Neurovascular Interventional Devices Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neurovascular Interventional Devices Forecast by Type
12.7 Global Neurovascular Interventional Devices Forecast by Application
13 Key Players Analysis
13.1 W.L. Gore & Associates
13.1.1 W.L. Gore & Associates Company Information
13.1.2 W.L. Gore & Associates Neurovascular Interventional Devices Product Portfolios and Specifications
13.1.3 W.L. Gore & Associates Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 W.L. Gore & Associates Main Business Overview
13.1.5 W.L. Gore & Associates Latest Developments
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Information
13.2.2 Abbott Laboratories Neurovascular Interventional Devices Product Portfolios and Specifications
13.2.3 Abbott Laboratories Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Abbott Laboratories Main Business Overview
13.2.5 Abbott Laboratories Latest Developments
13.3 Stryker Corporation
13.3.1 Stryker Corporation Company Information
13.3.2 Stryker Corporation Neurovascular Interventional Devices Product Portfolios and Specifications
13.3.3 Stryker Corporation Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Stryker Corporation Main Business Overview
13.3.5 Stryker Corporation Latest Developments
13.4 Medtronic PLC
13.4.1 Medtronic PLC Company Information
13.4.2 Medtronic PLC Neurovascular Interventional Devices Product Portfolios and Specifications
13.4.3 Medtronic PLC Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Medtronic PLC Main Business Overview
13.4.5 Medtronic PLC Latest Developments
13.5 Terumo Corporation
13.5.1 Terumo Corporation Company Information
13.5.2 Terumo Corporation Neurovascular Interventional Devices Product Portfolios and Specifications
13.5.3 Terumo Corporation Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Terumo Corporation Main Business Overview
13.5.5 Terumo Corporation Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Neurovascular Interventional Devices Product Portfolios and Specifications
13.6.3 Johnson & Johnson Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Penumbra, Inc.
13.7.1 Penumbra, Inc. Company Information
13.7.2 Penumbra, Inc. Neurovascular Interventional Devices Product Portfolios and Specifications
13.7.3 Penumbra, Inc. Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Penumbra, Inc. Main Business Overview
13.7.5 Penumbra, Inc. Latest Developments
13.8 Boston Scientific Corporation
13.8.1 Boston Scientific Corporation Company Information
13.8.2 Boston Scientific Corporation Neurovascular Interventional Devices Product Portfolios and Specifications
13.8.3 Boston Scientific Corporation Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Boston Scientific Corporation Main Business Overview
13.8.5 Boston Scientific Corporation Latest Developments
13.9 Merit Medical Systems, Inc.
13.9.1 Merit Medical Systems, Inc. Company Information
13.9.2 Merit Medical Systems, Inc. Neurovascular Interventional Devices Product Portfolios and Specifications
13.9.3 Merit Medical Systems, Inc. Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Merit Medical Systems, Inc. Main Business Overview
13.9.5 Merit Medical Systems, Inc. Latest Developments
13.10 Microport Scientific Corporation
13.10.1 Microport Scientific Corporation Company Information
13.10.2 Microport Scientific Corporation Neurovascular Interventional Devices Product Portfolios and Specifications
13.10.3 Microport Scientific Corporation Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Microport Scientific Corporation Main Business Overview
13.10.5 Microport Scientific Corporation Latest Developments
13.11 Cardinal Health
13.11.1 Cardinal Health Company Information
13.11.2 Cardinal Health Neurovascular Interventional Devices Product Portfolios and Specifications
13.11.3 Cardinal Health Neurovascular Interventional Devices Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Cardinal Health Main Business Overview
13.11.5 Cardinal Health Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂